Gefei Chen

Huddinge, AB 14152, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

MARK2 serves as a key regulator of host antiviral immunity through GEF-H1 phosphorylation.

MARK2 serves as a key regulator of host antiviral immunity through GEF-H1 phosphorylation.

Journal: Cell reports

Published: August 05, 2025

Bri2 BRICHOS, a molecular chaperone-like domain that can cross brain vascular endothelial cells and deliver proteins into neurons.

Bri2 BRICHOS, a molecular chaperone-like domain that can cross brain vascular endothelial cells and deliver proteins into neurons.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 02, 2025

Helicobacter pylori CagA protein is a potent and broad-spectrum amyloid inhibitor.

Helicobacter pylori CagA protein is a potent and broad-spectrum amyloid inhibitor.

Journal: Science advances

Published: June 11, 2025

Corrigendum to "Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer's disease" [Bioorg. Chem. 147 (2024) 107373].

Corrigendum to "Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer's disease" [Bioorg. Chem. 147 (2024) 107373].

Journal: Bioorganic chemistry

Published: January 21, 2025

Intravenous chaperone treatment of late-stage Alzheimer´s disease (AD) mouse model affects amyloid plaque load, reactive gliosis and AD-related genes.

Intravenous chaperone treatment of late-stage Alzheimer´s disease (AD) mouse model affects amyloid plaque load, reactive gliosis and AD-related genes.

Journal: Translational psychiatry

Published: September 30, 2024

Small Molecule Decoy of Amyloid-β Aggregation Blocks Activation of Microglia-Like Cells.

Small Molecule Decoy of Amyloid-β Aggregation Blocks Activation of Microglia-Like Cells.

Journal: Journal of Alzheimer's disease : JAD

Published: September 06, 2024

Liquid-liquid crystalline phase separation of spider silk proteins.

Liquid-liquid crystalline phase separation of spider silk proteins.

Journal: Communications chemistry

Published: July 18, 2024

Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer's disease.

Synthesis and biological evaluation of Halogen-Substituted novel α-Ketoamides as potential protein aggregation modulators in Alzheimer's disease.

Journal: Bioorganic chemistry

Published: February 21, 2024

Molecular basis for different substrate-binding sites and chaperone functions of the BRICHOS domain.

Molecular basis for different substrate-binding sites and chaperone functions of the BRICHOS domain.

Journal: Protein science : a publication of the Protein Society

Published: February 06, 2024

Potential of molecular chaperones for treating Alzheimer's disease.

Potential of molecular chaperones for treating Alzheimer's disease.

Journal: Neural regeneration research

Published: November 24, 2023

Signal peptide peptidase-like 2b modulates the amyloidogenic pathway and exhibits an Aβ-dependent expression in Alzheimer's disease.

Signal peptide peptidase-like 2b modulates the amyloidogenic pathway and exhibits an Aβ-dependent expression in Alzheimer's disease.

Journal: Progress in neurobiology

Published: June 30, 2023

Identification of potential aggregation hotspots on Aβ42 fibrils blocked by the anti-amyloid chaperone-like BRICHOS domain.

Identification of potential aggregation hotspots on Aβ42 fibrils blocked by the anti-amyloid chaperone-like BRICHOS domain.

Journal: Nature communications

Published: May 18, 2023

Showing 1-12 of 55

Last Updated: 09/26/2026